T. Rowe Price Associates’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,519
Closed -$18K 2921
2023
Q2
$18K Hold
4,519
﹤0.01% 2867
2023
Q1
$24K Hold
4,519
﹤0.01% 2848
2022
Q4
$97K Hold
4,519
﹤0.01% 2723
2022
Q3
$58K Buy
4,519
+1,675
+59% +$26.2K ﹤0.01% 2814
2022
Q2
$58K Buy
2,844
+901
+46% +$33K ﹤0.01% 2842
2022
Q1
$216K Buy
1,943
+723
+59% +$90.3K ﹤0.01% 2687
2021
Q4
$202K Sell
1,220
-2,375
-66% -$411K ﹤0.01% 2759
2021
Q3
$640K Buy
3,595
+352
+11% +$71.6K ﹤0.01% 2259
2021
Q2
$613K Buy
3,243
+427
+15% +$72.8K ﹤0.01% 2291
2021
Q1
$541K Buy
2,816
+691
+33% +$160K ﹤0.01% 2329
2020
Q4
$457K Buy
+2,125
New +$474K ﹤0.01% 2279

Other funds holding VAPO

T. Rowe Price Associates's VAPO Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Vapotherm, Inc. Common Stock (VAPO) in Q3 2023, closing a stake of 4,519 shares — an estimated $18K sold.

T. Rowe Price Associates first reported a position in VAPO in Q4 2020 and held it in 11 quarters. The position peaked at $640K in Q3 2021. 30 funds tracked by Wall St. Rank hold VAPO as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Vapotherm, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 4,519 Vapotherm, Inc. Common Stock shares in Q3 2023, an estimated $18K.
  • T. Rowe Price Associates first reported a position in Vapotherm, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • T. Rowe Price Associates's Vapotherm, Inc. Common Stock position peaked at $640K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.